Literature DB >> 7731721

Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.

K E Munn1, R A Walker, J M Varley.   

Abstract

Ductal carcinoma in situ (DCIS) of the breast is commonly described as a premalignant lesion. Using PCR to amplify DNA from areas of tumour cells which have been microdissected from fixed material, we have studied the involvement of chromosome 1 in 19 cases of DCIS. A series of microsatellite repeat polymorphisms has been used to define regions of allelic imbalance and this has confirmed the involvement in DCIS of six of the regions previously implicated in studies of invasive breast tumours. This suggests that these regions may harbour tumour suppressor genes, the inactivation of which is important for the early stages of breast tumour development. Analysis of separate ducts from within the same tumour has revealed that the same genetic alterations are not necessarily present throughout the lesion. In addition we have found that in three cases where frank invasive carcinoma is also present, similar alterations can be detected in the in situ and invasive component.

Entities:  

Mesh:

Year:  1995        PMID: 7731721

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

Authors:  M Kasami; C L Vnencak-Jones; S Manning; W D Dupont; D L Page
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

Authors:  F Farabegoli; N Baldini; D Santini; C Ceccarelli; M Taffurelli; D Treré; M Derenzini
Journal:  Clin Mol Pathol       Date:  1996-04

Review 4.  Genome evolution in ductal carcinoma in situ: invasion of the clones.

Authors:  Anna K Casasent; Mary Edgerton; Nicholas E Navin
Journal:  J Pathol       Date:  2016-11-27       Impact factor: 7.996

5.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.

Authors:  K E Munn; R A Walker; L Menasce; J M Varley
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

Review 7.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.

Authors:  K E Munn; R A Walker; L Menasce; J M Varley
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

Review 9.  Gene therapy for carcinoma of the breast: Genetic ablation strategies.

Authors:  D T Curiel
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

10.  Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

Authors:  K L Marsh; J M Varley
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.